Noscapine HCl (CB3304)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Noscapine HCl (CB3304), covering 2016-10-07 to 2016-10-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]